Evidence mapPaperPMID 40679753Full record

ArticleDermatology and therapy2025

Well-Being in Psoriasis: Weighting its Components Using Best-worst Scaling Methodology.

Esteban Daudén, Isabel Belinchón, Elena Colominas-González, Pablo Coto, Pablo de la Cueva, Fernando Gallardo, Jose Luis Poveda, Esther Ramírez, Sandra Ros, Ricardo Ruíz-Villaverde and 2 more

Abstract read
In one paragraph

Article in Dermatology and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Esteban DaudénDepartment of Dermatology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Diego de León, 62, 28006, Madrid, Spain. estebandauden@gmail.com.ORCID http://orcid.org/0000-0002-0676-1260
Isabel BelinchónDepartment of Dermatology, Hospital General Universitario Dr Balmis-ISABIAL-UMH, Alicante, Spain.ORCID http://orcid.org/0000-0002-6007-7320
Elena Colominas-GonzálezDepartment of Pharmacy, Hospital del Mar, Barcelona, Spain.ORCID http://orcid.org/0000-0002-6835-2868
Pablo CotoDepartment of Dermatology, Hospital Vital Álvarez Buylla, Mieres, Spain.
Pablo de la CuevaDepartment of Dermatology, Hospital Universitario Infanta Leonor, Madrid, Spain.ORCID http://orcid.org/0000-0003-4807-3551
Fernando GallardoDepartment of Dermatology, Hospital del Mar, Barcelona, Spain.ORCID http://orcid.org/0000-0002-8996-3828
Jose Luis PovedaDepartment of Pharmacy, Hospital Universitario y Politécnico La Fe, Valencia, Spain.ORCID http://orcid.org/0000-0003-1800-6198
Esther RamírezDepartment of Pharmacy, Hospital Universitario de La Princesa, Madrid, Spain.ORCID http://orcid.org/0000-0003-3053-7426
Sandra RosDepartments of Dermatology and Rheumatology, and Cardiac Transplant Unit, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.ORCID http://orcid.org/0000-0002-6267-1059
Ricardo Ruíz-VillaverdeDepartment of Dermatology, Hospital Universitario San Cecilio, Granada, Spain.ORCID http://orcid.org/0000-0002-0381-6174
Isabel CabezasOutcomes'10, Castellón de La Plana, Spain.ORCID http://orcid.org/0009-0008-8726-9913
Luis LizánOutcomes'10, Universidad Jaume I, Castellón de La Plana, Spain.ORCID http://orcid.org/0000-0001-6039-2454

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe Inpsight Project, established in 2021, aimed to define the concept of well-being in patients with psoriasis from a holistic perspective. Well-being was defined as a multi-dimensional concept that includes achieving emotional balance, having adequate overall health and control of the disease, enjoying positive social relationships, and being satisfied with disease care. However, while these components are recognized as integral to the concept, their relative contribution to achieving optimal well-being remains unclear. To address this gap, the present study aimed to determine the relative weight of each component in contributing to optimal well-being, focusing on a Spanish population.

methodsAn observational, descriptive, cross-sectional study was conducted in Spain using best-worst scaling (BWS). Two questionnaires were developed: one addressed to patients (33 item) and the other to healthcare professionals (HCPs) (18 item). The questionnaires collected sociodemographic and clinical (patients)/occupational (HCP) characteristics of the participants and the BWS scenarios. The 20 components of well-being were randomly distributed across 76 scenarios, with each component paired with others four times to ensure a comprehensive evaluation of all possible combinations. Participants assessed 9-10 randomly selected scenarios and identified the components they considered most (best) and least (worst) important for achieving optimal well-being.

resultsA total of 87 HCPs and 152 patients with psoriasis participated in the study. The five key components for patients were pain (P: 100.00), stress (P: 98.74), treatment satisfaction (92.21), itching (72.05), and lesions in functional locations (P: 69.09). From a HCP perspective, the most important components were mood disorders (100.00), pain (69.39), lesions in functional locations (49.34), self-esteem (49.24), and stigmatization/shame (45.22).

conclusionsThis study highlights the differences between patients and HCPs in their perception of the relative importance and relevance of the components contributing to the well-being of patients with psoriasis. Future research should focus on understanding the cumulative impact of psoriasis on patient well-being.

Indexed as

Best-worst scalingPsoriasisQuality of lifeWell-being

Identifiers

PMID40679753
PMCPMC12354440

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.